entertainment -WSS

entertainment

author：entertainment 2025-09-06 04:40:42 - browse：189

Palm Drive at Stanford University on March 28, 2023 — Palm Drive at the entrance to Stanford University. Brian Frank for STAT

The resignation of Marc Tessier-Lavigne as president of Stanford University following an investigation into irregularities in his past research marks more than just the startling downfall of the leader of one of the nation’s top research powerhouses. The case is likely to have broader repercussions, signaling a tipping point in an ongoing and often contentious debate about how to assign blame and credit in the increasingly collaborative world of research.

Science is a team sport. And while the lab leaders, or principal investigators, often get most of the attention for biomedical breakthroughs, they seldom run experiments. That work is left to postdoctoral researchers, graduate students, and others who peer through microscopes, labor away in mouse rooms, and spend countless hours pipetting. Instead, professors play more of a managerial role, supervising, critiquing, and offering big-picture feedback on the work that goes on in their lab.

It’s a longstanding arrangement, but one that leads to a thorny question when research is challenged: Who’s to blame? STAT put that question to Stanford faculty and students while reporting earlier this year on allegations of image manipulation and other misconduct related to research in Tessier-Lavigne’s lab, as well as researchers at other institutions. The answer varied depending on whom you asked.

Graduate students stressed that since faculty have no qualms using work done in their labs to land grants, win prizes, and build prestige, they should ultimately be accountable for problems with the science done under their supervision. Faculty generally agree, at least in principle, but are often quick to say that there are limits to how closely they can scrutinize their lab’s work, and that team science is in part based on trust. It’s an argument Tessier-Lavigne cited in his own statement about his resignation.

It’s also one he said wasn’t good enough.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Report captures long Covid’s disabling effects and policy challenges

hotspot

WSS

Statins may not be needed by millions of people, study suggests

Lilly's Alzheimer's drug donanemab backed by FDA advisers

What to watch for from Zogenix and Amicus clinical trials

Former reverend arrested for allegedly killing 8

UHS says company favors patients whose insurance pays more

Senate panel puts off hardest PBM reforms for another day

focus

entertainment

entertainment

Jerome Adams on the need for new antivirals for Covid

Coercive sterilizations revealed by STAT prompt outrage

Activists slam private health insurers over coverage restrictions

Why patients can’t get everything they want on drug pricing

Medicare details structure of new drug price negotiation program

My daughter's legacy lives on through her writing, phage therapy

Psychedelics group wrestles with new pharma identity

New lawsuit accuses health insurer Cigna of denying claims in bulk

As demand for Covid shots wanes, Moderna seeks its next success

New report analyzes digital physical therapy solutions' effectiveness

Wikipedia

How faith leaders like me can help address America's obesity epidemic

Lilly's Alzheimer's drug donanemab backed by FDA advisers

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

UHS says company favors patients whose insurance pays more

How doctors’ personal politics affect patients

The haunting brain science of long Covid

knowledge

hotspot

hotspot

hotspot